- Home
- CGON vs SOC Comparison
CGON vs SOC Comparison
Compare CGON & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- SOC
- Stock Information
- Founded
- CGON 2010
- SOC 2020
- Country
- CGON United States
- SOC United States
- Employees
- CGON N/A
- SOC N/A
- Industry
- CGON
- SOC
- Sector
- CGON
- SOC
- Exchange
- CGON NYSE
- SOC Nasdaq
- Market Cap
- CGON 2.3B
- SOC 2.2B
- IPO Year
- CGON 2024
- SOC N/A
- Fundamental
- Price
- CGON $29.08
- SOC $24.52
- Analyst Decision
- CGON Strong Buy
- SOC Buy
- Analyst Count
- CGON 10
- SOC 3
- Target Price
- CGON $65.11
- SOC $25.00
- AVG Volume (30 Days)
- CGON 809.2K
- SOC 1.3M
- Earning Date
- CGON 02-02-2025
- SOC 02-20-2025
- Dividend Yield
- CGON N/A
- SOC N/A
- EPS Growth
- CGON N/A
- SOC N/A
- EPS
- CGON N/A
- SOC N/A
- Revenue
- CGON $684,000.00
- SOC N/A
- Revenue This Year
- CGON $210.00
- SOC N/A
- Revenue Next Year
- CGON N/A
- SOC $606.07
- P/E Ratio
- CGON N/A
- SOC N/A
- Revenue Growth
- CGON 258.12
- SOC N/A
- 52 Week Low
- CGON $25.77
- SOC $10.11
- 52 Week High
- CGON $50.23
- SOC $28.67
- Technical
- Relative Strength Index (RSI)
- CGON 44.86
- SOC 58.21
- Support Level
- CGON $27.70
- SOC $21.76
- Resistance Level
- CGON $29.69
- SOC $25.22
- Average True Range (ATR)
- CGON 1.43
- SOC 1.21
- MACD
- CGON 0.16
- SOC 0.11
- Stochastic Oscillator
- CGON 31.29
- SOC 74.19
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About SOC Sable Offshore Corp. Common Stock
Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California.